Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report - Zhou, Qinfei; Zhao, Jiazheng; Wang, Jie; Bao, Guanai; Gong, Li-Yan (Annals of Palliative Medicine, 2020)